TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ITM PASSION FOR PRECISION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

ITM PASSION FOR PRECISION

ST13

US500000090447337

Class

5, 10, 42, 44

Filing

90447337

Registration

6546779

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

12

Latest update

05/19/2022

Classification

Registered

Trademark type

Combined

Nice classes

5, 10, 42, 44

Filing date

01/04/2021

Registration date

11/02/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/02/2021

Last transaction

11/02/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

94

Owner location

GARCHING, EU

Examiner

WILKE, JOHN

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized letters "ITM" with two dots coming from the top of the "i" all positioned above the phrase "PASSION FOR PRECISION".

Holders and representatives

Holders

I. S. (pessoa física)
ITM Isotopen Technologien München AG

Representatives

KARI MOYER-HENRY LEWIS KOHN & WALKER LLP

Technical classification

Nice Classes

Class 5Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy and radiopharmaceutical preparations for positron emission tomography (PET) or single photon emission tomography (SPECT), target radionuclide and peptide receptor radionuclide therapy (PRRT); theranostics in the field of precision oncology; radiopharmaceutical products, namely, lutetium-containing precursors; solutions for radioactive labelling; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing radioisotopes, e.g. lutetium-177, actinium-225, yttrium-90 for treatment and radioisotopes such as gallium-68 or fluorine-18 for diagnosis of tumors; target radiopharmaceuticals containing a target molecule, e.g. peptide or antibody, depending on the indication and a medical radioactive isotope; radiopharmaceuticals containing gallium and its complexes, gallium-68 DOTATOC; 177Lu-edotreotide preparations for targeted radionuclide therapy in patients with neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET); radiopharmaceuticals for use in the therapy of GEP-NET, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer; radiopharmaceuticals containing radioisotopes with short half-lives, such as gallium-68 or fluorine-18 for diagnostic applications; radiopharmaceuticals for use with high-sensitivity molecular imaging technologies such as PET (positron emission tomography) or SPECT (single photon emission tomography), for imaging organs and lesions and for early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular lutetium-177, actinium-225 or yttrium-90 for the treatment of tumor diseases

Class 10

Medical instruments, apparatus and containers for the application of radiopharmaceutical and radiodiagnostic preparations; control, regulating and measuring apparatus as parts of medical instruments, apparatus and containers included in this class, in particular apparatus for therapy and diagnosis with a radiotherapeutic or radiodiagnostic substance; radionuclide generators for radiopharmaceutical purposes

Class 42

Conducting clinical trials in all stages and with various indications, particularly in oncology; conducting phase III clinical trials with target radiopharmaceutical 177Lu-Edotreotide in patients with neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET)

Class 44

Medical services, in particular services in the field of radiotherapeutic and radiodiagnostic oncology, cardiology, angiology, neuroradiology and nuclear medicine and brachytherapy, including intercavitary, interstitial and intravascular brachytherapy, radionuclide labelling, PET and SPECT scanning and target radionuclide therapy, peptide receptor radionuclide therapy (PRRT), personal nuclear medicine and precision oncology

Publications

History of USPTO decisions and trademark events.

12 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/19/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/02/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/17/2021

PUBO

PUBLISHED FOR OPPOSITION

08/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/28/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/13/2021

DOCK

ASSIGNED TO EXAMINER

07/12/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/03/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/02/2021

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

01/28/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

01/28/2021

NWAP

NEW APPLICATION ENTERED

01/07/2021

Continuous trademark protection

Get notified about every new filing that threatens ITM PASSION FOR PRECISION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.